The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...

It is a leader in the continuous glucose monitoring (CGM) market, thanks to devices such as the G7 ... use DexCom, more companies will make their insulin pens, pumps, health apps, etc., compatible ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0% ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across ...

Shares of DexCom Inc. DXCM slipped 1.74% to $73.80 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to 5,667.56 and ...

Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego ...